Marinus Pharmaceuticals (MRNS)
(Delayed Data from NSDQ)
$1.51 USD
+0.06 (4.14%)
Updated May 3, 2024 04:00 PM ET
After-Market: $1.51 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/08/2024
Time: BMO |
3/2024 | $-0.68 | 0.74% |
Earnings Summary
For their last quarter, Marinus Pharmaceuticals (MRNS) reported earnings of -$0.74 per share, missing the Zacks Consensus Estimate of -$0.64 per share. This reflects a negative earnings surprise of 15.63%. Look out for MRNS's next earnings release on May 08, 2024. For the next earning release, we expect the company to report earnings of -$0.68 per share, reflecting a year-over-year decrease of 1.49%.
Earnings History
Price & Consensus
Zacks News for MRNS
Marinus (MRNS) Down 83% on Lead Drug Falling Short in Seizure Study
MRNS: What are Zacks experts saying now?
Zacks Private Portfolio Services